Skip to content

Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study

Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02128139
Acronym
EndoDev
Enrollment
300
Registered
2014-05-01
Start date
2012-04-30
Completion date
2015-10-31
Last updated
2025-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective Endocarditis

Keywords

Infective endocarditis, Developing country, Global health, Cardiac surgery, Heart valve disease, Bacteremia

Brief summary

Introduction. Comprehensive data on infective endocarditis in developing countries are scarce. Objectives: Description of the characteristics (clinical and microbiological) and assessment of the outcomes of infective endocarditis in low-income countries. Methods : Prospective, Observational, Multicentre study. Inclusion criteria: patients aged over 1 year fulfilling the modified Duke criteria for infective endocarditis. Exclusion criteria: patient included during a previous infective endocarditis episode. Outcomes measures: Mortality at 6 months follow-up; mortality at 1 month follow-up; access to antibiotic treatment (modalities and duration), hospital length of stay and reason for discharge, and cardiac surgery when indicated. Duration: One year (June 2014- June 2015)

Interventions

None listed

Sponsors

War Memorial Hospital
CollaboratorOTHER
Centers for Disease Control and Prevention
CollaboratorFED
Oxford University Hospitals NHS Trust
CollaboratorOTHER
St. Elizabeth Catholic General Hospital Shisong, Cameroun
CollaboratorUNKNOWN
CHU de Brazzaville, Congo Brazzaville
CollaboratorUNKNOWN
Polyclinique International de Bamako, Mali
CollaboratorUNKNOWN
CHR de Saint-Louis Lt Colonel Mamadou Diouf, Sénégal
CollaboratorUNKNOWN
Hôpital Général de Grand Yoff de Dakar, Sénégal
CollaboratorUNKNOWN
Bafoussam Regional Hospital, Cameroon
CollaboratorUNKNOWN
Hospital Laquinitinie de Douala
CollaboratorUNKNOWN
Yaounde Central Hospital
CollaboratorOTHER_GOV
National Hospital of Niamey
CollaboratorOTHER
Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, Benin
CollaboratorUNKNOWN
Hospital General De Douala
CollaboratorOTHER
Eduardo Mondlane University
CollaboratorOTHER
Laos Oxford Mahosot Wellcome Research Unit
CollaboratorUNKNOWN
Mulago Hospital, Uganda
CollaboratorOTHER
Fann Hospital, Senegal
CollaboratorUNKNOWN
Institute of Cardiology Abidjan
CollaboratorUNKNOWN
Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged over 1 year diagnosed with infective endocarditis according to the modified Duke criteria

Exclusion criteria

* Already included for a previous episode of infective endocarditis (i.e., relapse or reinfection)

Design outcomes

Primary

MeasureTime frame
Mortality at 1 month follow-up1 month

Secondary

MeasureTime frame
Mortality at 6 months follow-up6 months

Other

MeasureTime frameDescription
Access to cardiac surgery6 monthsHeart surgery is not available in many low-income countries. One of the objectives is to assess whether guidelines can be applied in low-secourced settings.

Countries

Fiji, Laos, Mozambique, Senegal, Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026